Onkure Therapeutics Inc (OKUR) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Onkure Therapeutics Inc   (NASDAQ: OKUR)

Select the Financial Report: Select the Period:


Description of Onkure Therapeutics Inc's Business Segments


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.



Annual Report on Onkure Therapeutics Inc Divisions, Sales by Country

 


Twelve months ended 2025
OKUR s Annual Revenue by Geography and Business Segments Sales
(in millions $)		 %
(of total Sales)
Total 3.43 100 %


Twelve months ended 2025
OKUR s Annual Income by Country and Business Segments Income
(in millions $)		 %
(Profit Margin)
Total -59.52 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Total 100.41 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.